SecBot SecBot
PRESS-RELEASE ·Filed Oct 27, 2026

TEVA

Teva Pharmaceutical Industries Ltd
NEUTRAL
Impact 5/10
Processed8h 53m ago Wirepress-3388911
Press release · M&A

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3388911
44 reports for TEVA
Performance horizon
75% Hit rate @ T+60 6 of 8 directional calls Went positive at some point 13 of 14 best @ T+60▲ +33.06%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Oct 27, 2026
today
Press Release
NEUTRAL ★ 5/10
$39.22awaiting T+60—$40.39 (+2.98%)
Oct 15, 2026
12d ago
Institutional Cluster
BEARISH ★ 4/10
$41.11awaiting T+60—$40.39 (+1.75%)
Oct 8, 2026
19d ago
3
NEUTRAL ★ 2/10
$41.10awaiting T+60—$40.39 (−1.73%)
Oct 2, 2026
25d ago
Press Release
BULLISH ★ 6/10
$39.53awaiting T+60—$40.39 (+2.18%)
Oct 2, 2026
25d ago
Press Release
BULLISH ★ 5/10
$39.53awaiting T+60—$40.39 (+2.18%)
Sep 30, 2026
27d ago
Press Release
NEUTRAL ★ 2/10
$39.31awaiting T+60—$40.39 (+2.75%)
Sep 28, 2026
29d ago
Press Release
BULLISH ★ 7/10
$39.81awaiting T+60—$40.39 (+1.46%)
Sep 23, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$40.22awaiting T+60—$40.39 (+0.42%)
Sep 23, 2026
4w ago
Press Release
NEUTRAL ★ 1/10
$40.22awaiting T+60—$40.39 (+0.42%)
Sep 22, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$39.01awaiting T+60—$40.39 (−3.54%)
Showing 10 of 44

US Market Status

Market Closed — Opens Wed (16h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh TEVA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access